Diagnosis
Top Base the diagnosis on clinical findings of acute nephritis or the presence of inflammatory changes in the glomeruli on kidney biopsy.
1.1 Recognize the broad spectrum of symptoms that can be associated with acute glomerulonephritis.
Recommendations
• Appreciate the broad spectrum of clinical presentations of acute glomerulonephritis, ranging from minor symptoms to symptoms of acute kidney injury, including: 
Evidence
• A large outbreak of acute glomerulonephritis in Nova Serrana, Brazil, was caused by group C Streptococcus; of 134 patients identified, 48% had broad symptomatology ranging from fever and dark urine to nausea, vomiting, and confusion (1).
• Reviews show that PSGN, the prototype of acute glomerulonephritis, classically presents with symptoms of acute glomerulonephritis 7 to 21 days after the streptococcal pharyngitis (2; 3; 4; 5).
• Although acute glomerulonephritis occurs more commonly in children and young adults, a review at a hospital in Uberaba, Brazil, found that 82 patients between the ages of 14 and 64 developed acute glomerulonephritis after an upper airway or skin infection. This study revealed the varied age of disease presentation (6) .
Rationale
• Acute nephritis is an inflammatory state in the kidneys and can often be associated with fever, particularly when the acute glomerulonephritis is due to infection (e.g., PSGN) or associated with an autoimmune disease (e.g., SLE).
• Acute glomerulonephritis may also present with dark urine (because of hematuria or decreased free water clearance).
• Nausea, vomiting, and confusion are symptoms of acute kidney injury that may be associated with acute glomerulonephritis.
• Autoimmune diseases associated with systemic manifestations, such as rashes or joint pain, can also cause acute glomerulonephritis.
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Comments
• Recognize that the diagnosis of acute glomerulonephritis begins with a broad differential diagnosis (e.g., the etiology of edema); when further information is obtained (e.g., elevated creatinine, hematuria/proteinuria) the diagnosis can be narrowed.
• Juvenile acute nonproliferative glomerulonephritis is a clinicopathological entity that is distinguished from acute PSGN by the presence of normal serum complement and the absence of diffuse proliferation of mesangial cells in the glomeruli (7).
1.2 Perform a detailed physical exam to look for signs of acute nephritis and the specific etiology of the acute glomerulonephritis.
Recommendations
• Look for signs of acute nephritis:
 High BP  Edema  Asterixis, pericardial rub, and encephalopathy, suggesting acute kidney injury
• Look for signs that suggest a specific etiology of acute glomerulonephritis: 
Evidence
• Consensus.
Rationale
• Many systemic diseases can cause acute glomerulonephritis, and a detailed physical exam may uncover a specific etiology or narrow the list of potential etiologies.
Obtain lab data to support the diagnosis of acute glomerulonephritis.
Recommendations
• Look for hematuria, with or without proteinuria, on urine dipstick.
• Obtain fresh urine for phase-contrast microscopy to look for erythrocyte casts.
• Quantify proteinuria either with a spot urine test for protein/creatinine ratio (if >2 is significant) or 24-hour urine collection (if >2 g/24 hours is suggestive of glomerular pathology).
• Obtain serial serum creatinine measurements and estimated GFR (MDRD formula) to detect the presence of and any worsening renal insufficiency.
• See table Laboratory and Other Studies for Acute Glomerulonephritis and Underlying Disease in Acute Glomerulonephritis.
• See figure Erythrocyte Cast.
• See figure Normal Glomerular Capillary Diagram.
Evidence
• In multiple studies correlating initial urinalysis findings with the subsequent kidney biopsy results, the presence of erythrocyte casts or dysmorphic urinary erythrocytes corresponded to a glomerular origin of the hematuria (13; 14; 15).
• Dysmorphic erythrocytes are a sensitive but not specific marker of hematuria of glomerular origin. In a review of the urine microscopy of 27 normal volunteers, 31 patients undergoing kidney biopsy, and 28 patients with lower GI bleeding, dysmorphic erythrocytes in the urine strongly suggested glomerular etiology (14) .
• A study evaluated midstream urine samples from 88 patients evaluated for hematuria. Fifty-eight of the patients were diagnosed with a glomerular source of hematuria, and 55 of those had dysmorphic erythrocytes. None of the 30 patients diagnosed with nonglomerular hematuria had dysmorphic erythrocytes (13).
• In an older cohort study of 30 patients with kidney disease from varying causes, high urinary albumin excretion (and high total urinary protein) was found in patients with glomerular disease (16).
• A retrospective study of 112 patients in China with acute PSGN found that children had a higher incidence of macroscopic hematuria than adults (58.3% vs. 32.7%, P<0.05) (17) .
• A 2012 review provides an excellent summary of the pathophysiology and causes of MPGN (18) .
Rationale
• Dysmorphic erythrocytes and erythrocyte casts in the urine suggest acute glomerulonephritis; however, dysmorphic erythrocytes are difficult to appreciate.
• The frequency of serum creatinine measurements may vary between days to weeks, depending on the presence of acute kidney injury and the degree of renal function loss.
Comments
• Acute glomerulonephritis is suspected by the presence of an active urine sediment (the presence of hematuria, proteinuria, erythrocyte casts) in the appropriate clinical setting (hypertension, edema, renal insufficiency). Urine dipstick and urine microscopy can detect blood and protein in the urine.
• Urine microscopy should only be done by experienced clinicians.
• Creatinine clearance calculated from equations such as the Cockcroft-Gault and MDRD may not be accurate if kidney function is not in steady state.
1.4
Obtain additional lab tests to help determine the etiology of acute glomerulonephritis.
Recommendations
• Based on clinical suspicion of specific underlying diseases, obtain additional studies, including: • Consider a skin biopsy of any purpuric rash to confirm leukocytoclastic vasculitis.
Evidence
• Reviews stress that documentation of a streptococcal throat infection in the setting of acute glomerulonephritis would increase suspicion for PIGN. PIGN, lupus nephritis, cryoglobulinemic glomerulonephritis, and MPGN are associated with low complement levels (19; 20) .
• Many forms of acute glomerulonephritis are associated with specific serologic markers, such as anti-GBM antibody for Goodpasture's disease, pANCA, cANCA for systemic vasculitis, and cryoglobulins for cryoglobulinemia (21) .
• A retrospective study in Taiwan identified 20 adults with infection-associated glomerulonephritis. All of these patients developed acute renal failure and most of them required dialysis support. Staphylococcus was identified as the infectious agent most frequently, in 60% of the cases (22) .
Rationale
• Many different infections can cause acute glomerulonephritis.
• Hepatitis B and C are associated with acute glomerulonephritis, specifically cryoglobulinemic glomerulonephritis and MPGN; SLE, small vessel vasculitis, and anti-GBM disease (Goodpasture's disease) can also cause acute glomerulonephritis.
• Complement levels may help narrow the differential diagnosis of acute glomerulonephritis.
• Acute glomerulonephritis can be classified based on low complement levels (PIGN, lupus nephritis, cryoglobulinemic glomerulonephritis, MPGN) or normal complement levels (IgA nephropathy, ANCA-associated glomerulonephritis, anti-GBM disease, fibrillary glomerulonephritis).
Comments
• Results from many of these serologic tests can take more than 1 day to obtain. Depending on clinical suspicion, some or all of the tests might be sent at the initial evaluation to help expedite the diagnosis of acute glomerulonephritis.
1.5 Make an early referral for a kidney biopsy if there is a high index of suspicion for acute glomerulonephritis to enable initiation of appropriate treatment.
Recommendations
• Obtain early referral to a nephrologist for a kidney biopsy if there is a high index of suspicion for acute glomerulonephritis, especially if there is evidence of systemic vasculitis (with or without ANCA or lupus serology positivity) or anti-GBM positivity, or worsening of renal function, hypertension, or proteinuria.
Evidence
• As in most glomerulopathies, patients who develop progressive disease typically have elevated serum creatinine, hypertension, or proteinuria at diagnosis (23) .
Rationale
• Early treatment is more likely to result in preservation of or improvement in renal function. Specific treatment may be indicated, depending on disease.
• Patients with glomerular disease may benefit from long-term follow-up with a nephrologist.
Comments
• A kidney biopsy is done to help diagnose the etiology of acute glomerulonephritis, guide treatment, and provide prognostic information. 
Recommendations
• Classify glomerulonephritis into infectious or noninfectious processes based on history and physical exam.
• Recognize that several other conditions may present with acute kidney injury, hematuria, proteinuria, and hypertension.
• Use history, physical exam, and urinalysis to differentiate acute glomerulonephritis from other conditions that present similarly and to classify acute glomerulonephritis by its etiology.
• See table Differential Diagnosis of Acute Glomerulonephritis.
• See table Etiologies of Acute Glomerulonephritis.
• See module Acute Kidney Injury.
Evidence
Rationale
• Elements in the history, physical exam, and urinalysis may individually suggest a diagnosis of acute glomerulonephritis, but when evaluated further they often implicate another diagnosis. 
Recommendations
• Consult a nephrologist to help with the diagnostic work-up, including a kidney biopsy; do so urgently if there is evidence of ongoing loss of renal function as manifested by an increasing creatinine level or a decreasing estimated GFR (MDRD formula).
• Consult other specialists, such as a rheumatologist, depending on the suspected etiology of underlying systemic disease.
Evidence
• Acute glomerulonephritis can present as an RPGN with rapid loss of renal function, requiring expeditious diagnosis and kidney biopsy (2).
Rationale
• Acute glomerulonephritis can result in a rapid decline in renal function; a timely diagnosis, often requiring a kidney biopsy, allows appropriate treatment that can spare renal function and even reverse renal injury.
• Rheumatologists can help diagnose patients with systemic disease, such as vasculitis, causing glomerulonephritis.
Consult a nephrologist for patients with acute glomerulonephritis who develop acute kidney injury and other specialists as needed.
Recommendations
• Consult a nephrologist for management of acute kidney injury and complications, such as:  Acid-base abnormalities (e.g., severe metabolic acidosis)
• Consult a nephrologist or rheumatologist to manage immunosuppressive therapy, depending on the underlying etiologies.
Evidence
• KDIGO's 2012 guideline is available to help guide management for acute glomerulonephritis (28).
• In 2002, K/DOQI issued guidelines for the management of chronic kidney disease (37), a possible sequelae of acute glomerulonephritis.
Rationale
• Nephrologists can help manage the complications of acute kidney injury (anemia, bone disease, hyperphosphatemia, acidosis) and help prepare the patient for renal replacement therapy if needed.
• A specialist may have more experience with the clinical course of the disease, with titration of immunosuppressive medications to manage the disease, and with the side effects of the immunosuppressive medications.
Comments
• There is no definitive rule for when a patient should see a nephrologist. The threshold of a GFR of 30 mL/min does not take into account the rate of fall of GFR, patient preferences, or the familiarity of the patient's primary physician with managing chronic kidney disease.
Hospitalization
Top
Hospitalize patients with acute glomerulonephritis and worsening renal function and its complications.
3.1 Hospitalize patients with acute glomerulonephritis and a decline in renal function, acute kidney injury, complications of acute kidney injury, or a severe manifestation of the underlying systemic disease.
Recommendations
• Admit a patient with an increasing creatinine level for complete evaluation of acute kidney injury and to determine and initiate the appropriate treatment based on the diagnosis.
• Admit a patient with complications of acute kidney injury (volume overload, electrolyte abnormalities, hypertension) for management of these complications, which may include medications, dialysis, or both.
Evidence
• A 1996 review discussed the management of acute kidney injury and dialysis (25) .
Rationale
• Renal function can deteriorate rapidly in the setting of acute glomerulonephritis.
• Other serious electrolyte abnormalities can occur with acute kidney injury and be life threatening.
• Inpatient hospitalization allows a more efficient evaluation and monitoring of the condition; procedures and tests, such as dialysis or a kidney biopsy, can be done more efficiently while the patient is hospitalized. • Encourage smoking cessation.
• Consider the need for dialysis in patients with severe kidney injury.
• Consider referral to a renal dietitian for patients with hyperkalemia or hyperphosphatemia.
• Consider plasma exchange in patients with Goodpasture's syndrome and ANCA vasculitis.
• See module Smoking Cessation.
Evidence
• Acute glomerulonephritis is a salt-retaining state, likely due to a renal response to the decreased GFR (2).
• Salt restriction is helpful for volume management, particularly in patients with nephrotic-range proteinuria (21).
• In a retrospective multicenter case-control study, smoking increased the risk for end-stage renal disease in men with inflammatory renal disease. In men with IgA nephropathy, smoking was found to increase the risk for progressing to acute kidney injury in a dose-dependent manner (26).
• Smoking has been implicated in the progression of autosomal dominant polycystic kidney disease (26) and in diabetic nephropathy (27) .
Rationale
• Acute glomerulonephritis is a salt-retaining state; limiting salt intake should decrease salt retention, decrease edema, and help to improve BP control.
• Acute dialysis helps correct the metabolic abnormalities associated with acute kidney injury, such as hyperkalemia, acidosis, and volume overload.
• Smoking is associated with a faster progression of kidney disease.
Comments
• Salt restriction and diuretics have complementary mechanisms of action in the management of volume overload.
Treat the clinical manifestations of acute glomerulonephritis regardless of etiology.
Recommendations
• Treat edema with a loop diuretic if needed.
• Treat hypertension with appropriate antihypertensive agents, such as β-blockers, centrally acting agents, and calcium-channel blockers.
• Avoid ACE inhibitors and angiotensin-receptor blockers early in the course of acute glomerulonephritis.
• Correct:
 Acidosis with oral sodium bicarbonate  Anemia with erythropoietin  Hypocalcemia and hyperphosphatemia with alfacalcidol and phosphate binders
• See table Drug Treatment for Acute Glomerulonephritis.
Evidence
• KDIGO's 2012 guideline is available to help guide management of acute glomerulonephritis (28).
• ACE inhibitors can cause a decrease in GFR by altering renal hemodynamics (29; 30) . This decrease can confuse clinicians who are following a patient with acute glomerulonephritis and are monitoring for acute kidney injury.
Rationale
• The use of ACE inhibitors or angiotensin-receptor blockers in the early stages of acute glomerulonephritis may cause worsening renal function through decreasing effective renal blood flow.
Treat the underlying etiology of acute glomerulonephritis.
Recommendations
• Use appropriate antibiotics.
• Use corticosteroids, cyclophosphamide, or mycophenolate mofetil alone or in combination to treat patients with autoimmune-mediated glomerulonephritis (i.e., SLE, ANCA vasculitis, anti-GBM, cryoglobulinemic glomerulonephritis).
• Use corticosteroids, fish oil, or mycophenolate mofetil in patients with IgA nephropathy.
• Use steroids, dipyridamole, or ASA to treat MPGN and any underlying infectious disease that may be a contributing factor, such as hepatitis C.
• Consider immunosuppression therapy after a histologic diagnosis of acute glomerulonephritis is confirmed, recognizing that the type and duration of immunosuppression also depends on the histologic findings.
• For hepatitis C-infected patients with chronic kidney disease, stage 1 or 2, and glomerulonephritis, consider combined antiviral treatment using pegylated interferon and ribavirin as in the general population.
• For hepatitis C-infected patients with chronic kidney disease, stage 3, 4, or 5, and glomerulonephritis, not yet on dialysis, consider monotherapy with pegylated interferon, with doses adjusted to the level of kidney function.
• For patients with hepatitis C and mixed cryoglobulinemia (IgG/IgM) with nephrotic proteinuria or evidence of progressive kidney disease or an acute flare of cryoglobulinemia, consider plasmapheresis, rituximab, or cyclophosphamide, in conjunction with iv methylprednisolone and concomitant antiviral therapy.
• For patients with hepatitis B infection and glomerulonephritis, treat with interferon-α or with nucleoside analogues as recommended for the general population by standard clinical practice guidelines for hepatitis B infection.
• Initiate antiretroviral therapy in all patients with biopsy-proven HIV-associated nephropathy, regardless of CD4 count.
• See module Vasculitis.
• See module Systemic Lupus Erythematosus.
• See module Cryoglobulinemia.
• See module Hepatitis B.
• See module Hepatitis C.
• See module HIV Disease.
Evidence
• KDIGO's 2012 practice guideline for glomerulonephritis provides specific recommendations regarding the treatment of GN due to many causes (28).
• A study on patients with IgA nephropathy compared 4 months of oral steroids to placebo in patients with nephritic syndrome, with 17 patients in each group. There was no difference in GFR between the groups, but the steroid-allocated patients had a higher rate of remission of nephritic syndrome (31).
• Studies have shown that patients with IgA nephropathy who were treated with fish oil were less likely to have worsening renal function (32; 33).
• A review article discussed the role of steroids, fish oil, tonsillectomy, and ACE inhibitors in the management of IgA nephropathy (34).
• Two small randomized trials assessed the effects of dipyridamole and aspirin in MPGN (35; 36). One study had nine patients in each arm and found a reduction in proteinuria in the treatment group as compared to control (35) . The other study found that the patients in the treatment group had slower decline of GFR compared to control (36) . The control group did have a rapid rate of GFR decline, and the study has been criticized for perhaps having unequal comparison groups and therefore exaggerating the benefit of treatment with dipyridamole and aspirin.
Rationale
• Corticosteroids and cyclophosphamide have been shown to improve the outcomes of autoimmune diseases in general and nephritis in particular.
• Treating an underlying infection is part of the management of these patients.
• Removal of the infection (and the immune response to the infection) is thought to help in the treatment of PIGN.
Vaccinate patients against pneumonia and influenza.
Recommendations
• Administer pneumonia vaccine to patients with glomerulonephritis and nephrotic syndrome.
• Administer influenza vaccination annually.
Evidence
• KDIGO's 2012 practice guideline for glomerulonephritis recommends vaccination for pneumonia and influenza (28) .
Rationale
• Patients with glomerulonephritis and nephrotic syndrome are at increased risk for invasive pneumococcal infection and should therefore receive the pneumonia vaccination along with an annual influenza vaccination. 
Recommendations
• Educate patients about the underlying disease that has caused acute glomerulonephritis, its course, and the prognosis.
• Instruct patients about measures of kidney function, such as creatinine or GFR.
• Make patients aware of the need to take medication dosages based on kidney function.
• Educate patients about potential nephrotoxins, such as NSAIDs and intravenous contrast dye.
• Educate patients to identify clinical symptoms and signs of renal insufficiency, such as:
• Inform patients with systemic forms of glomerulonephritis, such as SLE, about the nature of their underlying disease, other organ-system involvement, and symptoms or signs to watch for that may represent a recurrence or exacerbation of the underlying systemic disease.
Evidence
• Medications are a common cause of worsening renal function in patients with underlying kidney disease (25) .
Rationale
• Glomerulonephritis can cause permanent kidney damage.
• The dosages of some medicines need to be adjusted in renal insufficiency.
• Common medicines (e.g., NSAIDs, ACE inhibitors, contrast dyes) can affect renal function. • Ask about symptoms of systemic disease, such as arthralgia, skin rash, and dyspnea.
• Examine patient for asterixis, encephalopathy and signs of systemic diseases.
Evidence
• K/DOQI guidelines for management of chronic kidney disease resulting from any etiology were published in 2002 (37) .
Rationale
• Glomerulonephritis may cause kidney damage leading to renal insufficiency, which needs to be followed closely.
• Glomerulonephritis may be a recurrent disease; therefore, routine evaluation for symptoms and signs of recurrence is necessary.
Comments
• The follow-up interval is determined by the clinical situation. Initially, patients are usually followed more frequently to insure that the kidney function and disease course is stable. As the patient shows clinical stability over time, the interval between appointments can be increased. Specific serologic markers of underlying systemic disease, such as complement levels and anti-dsDNA titers, may need to be checked regularly. 
Glossary
Laboratory and Other Studies for Acute Glomerulonephritis and Underlying Disease in Acute Glomerulonephritis
Test Notes
Acute glomerulonephritis
Serum creatinine Provides a rough estimate of GFR Estimated GFR (MDRD formula) Practically the most accurate estimate of GFR BUN Another marker of renal function that is less robust than serum creatinine because of the influence of multiple factors, such as hydration status, catabolism, and diet
Urine microscopy for erythrocyte casts Erythrocyte casts are considered a hallmark of acute glomerulonephritis. Acute glomerulonephritis can also be present despite a lack of erythrocyte casts in the urine sediment (13; 14) . See figure Erythrocyte Cast
Urine microscopy for dysmorphic erythrocytes Dysmorphic erythrocytes, even in the absence of erythrocyte casts, suggest glomerular pathology Urine dipstick Active urinary sediment (microscopic hematuria with or without erythrocyte contrast) ± proteinuria Protein/creatinine ratio in the urine Proteinuria, confirmed with a protein to creatinine ratio, suggests renal pathology. Higher amounts of protein in the urine (>2 g/24-h period) usually indicate glomerular pathology 24-hour urine for protein Proteinuria >2 g/24 h suggests glomerular proteinuria Electrolytes Monitored because of potential derangements due to acute kidney injury. Close attention to serum potassium, calcium, bicarbonate, and phosphorus concentrations is needed
Ultrasound of the kidneys Often normal in patients with acute glomerulonephritis but is obtained routinely to exclude other etiologies of acute kidney injury. Enlarged kidneys or increased echogenicity may be noted in acute nephritis but is not a specific sign for acute glomerulonephritis Kidney biopsy Renal histology, which includes light, immunofluorescence, and electron microscopy, is the definitive investigation to establish the diagnosis of acute glomerulonephritis (24) Underlying disease in acute glomerulonephritis The history of vascular manipulation followed by acute kidney injury and embolic stigmata differentiates atheroembolic disease from acute glomerulonephritis HUS/TTP Both TTP and HUS are thrombotic microangiopathies representing a small-vessel dysfunction that can have systemic manifestations; therefore, they can present clinically similar to a vasculitis glomerulonephritis TTP has a classic pentad of findings: thrombocytopenia, anemia, fever, mental status changes, and acute kidney injury. HUS usually presents with thrombocytopenia, rash, acute kidney injury, and GI involvement. The clinical presentation of these entities distinguishes them from acute glomerulonephritis AIN = acute interstitial nephritis; ATN = acute tubular necrosis; BP = blood pressure; GI = gastrointestinal; HUS = hemolytic-uremic syndrome; TTP = thrombotic thrombocytopenic purpura. 
Additional agent
Sodium bicarbonate
Per protocol Flatulence, abdominal pain, volume expansion due to sodium load Correct acidosis = black box warning; AV = atrioventricular; bid = twice daily; CKD = chronic kidney disease; CNS = central nervous system; CrCl = creatinine clearance; CYP = cytochrome P450 isoenzyme; GI = gastrointestinal; HF = heart failure; HPA = hypothalamic-pituitary-adrenal; IM = intramuscular; IV = intravenous; PO = oral; qd = once daily; qid = four times daily; SC = subcutaneous; SIADH = syndrome of inappropriate secretion of antidiuretic hormone; tid = three times daily.
PIER provides key prescribing information for practitioners but is not intended to be a source of comprehensive drug information. 
Etiologies of Acute Glomerulonephritis
Infectious glomerulonephritis
Acute PSGN Classically, symptoms of upper respiratory infection (e.g., fever, sore throat) precede the development of glomerulonephritis by 1-3 wk. Other streptococcal infections (e.g., skin infections) can also precipitate PIGN.
Typically presents as an acute glomerulonephritis, manifesting as a systemic illness, including edema, hypertension, hematuria, and acute kidney injury.
Originally described as poststreptococcal glomerulonephritis, postinfectious glomerulonephritis can occur after infections by organisms other than streptococci, such as staphylococci or meningococci
Complement levels (C3 and C4) are usually low. Anti-DNAase B is used to document streptococcal infection with high sensitivity. ASO titers also can be followed to document streptococcal infection and resolution. A kidney biopsy result would show a proliferative glomerulonephritis, possibly with crescents, and subendothelial subepithelial deposits (humps) and mesangial deposits on electron microscopy Nonpoststreptococcal glomerulonephritis Infections, such as pneumonia, meningitis, endocarditis, and ventriculoatrial shunt infections, can precipitate an immune response resulting in acute glomerulonephritis
Complement levels (C3 and C4) are usually low and return to baseline values after resolution of the disease
Noninfectious glomerulonephritis
Primary
IgA nephropathy Most common glomerulonephritis worldwide. The classic presentation is hematuria 1-2 d after a sore throat (as compared to PIGN, which causes the hematuria 1-3 wk after the sore throat).
The clinical manifestations of IgA nephropathy range from asymptomatic microscopic hematuria to acute kidney injury
The diagnosis of IgA nephropathy is made by the predominance of IgA deposits on the immunofluorescence staining of the kidney biopsy Fibrillary glomerulonephritis A rare form of acute glomerulonephritis of unknown etiology. An abnormal protein deposition disease associated with proteinuria. Proteinuria may be the only clinical manifestation, unless it induces acute kidney injury
The diagnosis is made by recognizing the characteristic fibrillary proteins on electron microscopy Idiopathic MPGN This disease often presents as hematuria, proteinuria (often subnephrotic), and kidney injury of varying severity. It is associated with the presence of nephritic factors, which are autoantibodies that bind C3 convertase of the alternate complement pathway. Many of the historical cases thought to be "idiopathic" may have been associated with hepatitis C infection MPGN is diagnosed by the characteristic renal biopsy findings: proliferation, thickened capillary loops on light microscopy, and thickened glomerular basement membranes on electron microscopy with immune deposits Henoch-Schönlein purpura A clinical tetrad of abdominal pain, rash, arthralgia, and nephritis The diagnosis is usually made clinically. However, if there is progressive disease in terms of worsening renal function or proteinuria, then consider a kidney biopsy before considering immunosuppression therapy. A skin biopsy with a combination of leukocytoclastic vasculitis and IgA deposition is essentially diagnostic of Henoch-Schönlein purpura. The renal histology is similar to that of IgA nephropathy (38) Secondary SLE SLE is a systemic disease affecting multiple organ systems and is diagnosed by the criteria described by the American College of Rheumatology. Renal involvement is only one of the systemic manifestations of the disease A kidney biopsy is necessary to differentiate several patterns of renal lesions in the kidney
